abstract |
The invention relates to phenyl-1,2,4-oxadiazolone derivatives in all their stereoisomeric forms and mixtures in any ratio, and their physiologically acceptable salts and tautomeric forms showing agonist activity of PPARdelta. What is described are compounds of the formula I, (I) where the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable for the treatment and / or prevention of fatty acid metabolism disorders and glucose utilization disorders as well as disorders in which insulin resistance and demyelination and other neurodegenerative disorders of the central nervous system are involved. and peripheral. |